denotes an abstract that is clinically relevant.
denotes that this is a recommended PHD Trainee Session.
denotes that this is a ticketed session.Hematology Disease Topics & Pathways:
Research, clinical trials, Lymphoid Leukemias, Acute Myeloid Malignancies, Biological therapies, Clinical Practice (Health Services and Quality), Lymphomas, Clinical Research, health outcomes research, Plasma Cell Disorders, health disparities research, Diversity, Equity, and Inclusion (DEI) , Diseases, Therapies, Immunotherapy, Lymphoid Malignancies, Adverse Events, Myeloid Malignancies
Description:
The complexity of treating hematologic malignancies continues to grow rapidly with novel agents, BiTe therapy, CAR-T, and transplantation, which offer potentially a new horizon for patients struggling with these diseases. As these therapies are becoming the stand of care, the question of access remains a large factor in improving patient outcomes in the community where most of the cancer care is delivered. This educational session will explore the diagnostic, supportive, and treatment challenges that often present in the local setting with acute leukemia, high grade lymphomas, and multiple myeloma. We offer a case-based discussion for optimal management, as well as explore the role of clinical trials locally in terms of increasing access, diversity, options, and outcomes in the community.